• Scholar Rock Secures $550M Debt Facility from Blue Owl Capital
Scholar Rock - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeScholar Rock
Scholar Rock logo

Scholar Rock

0 followers

SRRK

Performance

About Scholar Rock

Scholar Rock is a Cambridge, Massachusetts-based biopharmaceutical company focused on discovering, developing, and delivering therapies that address diseases rooted in protein growth factors. The company uses a science-first approach to selectively target growth factor biology to treat serious conditions, with a pipeline spanning neuromuscular, cardiometabolic, immuno-oncology, fibrotic, and hematology indications. Scholar Rock emphasizes translating bold science into therapies that improve patients’ lives and offers information for patients, healthcare professionals, and investors through its newsroom and resources.

Recent News

No recent news for this company.

Recent Deals

Scholar Rock Secures $550M Debt Facility From Blue Owl Capital

March 3, 2026

Key Team Members

Jing L. Marantz, M.D., Ph.D., MBA

Chief Medical Officer

Tracey Sacco, MBA

Chief Commercial Officer

Akshay Vaishnaw M.D., Ph.D.

President, R&D

Caryn Parlavecchio

Chief Human Resources Officer

David Hallal

Chief Executive Officer & Chairman

Key Facts

HQ Location

Cambridge, United States

Founded

2012

Employees

201 - 500

Status

Public

Website

https://scholarrock.com